Role of serum fasting gastrin in screening for hypergastrinemic syndromes in duodenal ulcer disease
✍ Scribed by Francesco Di Mario; Mario Plebani; Lorena Gottardello; Giuseppe Battaglia; Fabio Vianello; Fabio Farinati; Giuseppe del Favero
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 590 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
✦ Synopsis
Basal serum gastrin levels were measured in 237 patients with endoscopically confirmed duodenal ulcer and were higher than normal in 16 cases. Protein meal gastrin stimulation was performed on this group of 16 patients and on a control group of 48 patients with normal basal gastrin concentrations but high rates of either ulcer recurrence or of complications (e.g., bleeding or perforation); 21 patients from the two groups were also tested for serum gastrin inhibition with secretin. Four cases (25%) of antral G-cell hyperfunction were found in the first group, plus 1 case compatible with Zollinger-Ellison syndrome (6.2%). Only 1 case (2°/o) of antral G-cell hyperfunction was found among the 48 controls. These results suggest the clinical utility of routine basal gastrin measurement in screening for hypergastrinemic patients with duodenal ulcer disease.